Yale University
Also known as: ABTC/Yale University | Alessandro Santin | Assistant Professor of Medicine (Medical Oncology) Yale University | Assistant Professor of Psychiatry; Associate Director, Alzheimer's Disease Research Unit; Faculty, Alzheimer's Disease Research Center (ADRC) | Associate Professor of Pediatrics, Yale School of Medicine | Associate Professor of Psychiatry; Director, Yale OCD Research Clinic | Barbara Burtness | Brett King | Bridgeport Hospital | Bridgeport Hospital, Bridgeport, CT | Chair, Department of PsychiatryYale University School of MedicineChief of Psychiatry, Yale-New Haven Hospital | Christina Kruuse | Clinic 15 - Yale University | Danbury Hospital | Danbury Hospital, Nuvance Health | Department of Pediatrics, Yale University School of Medicine | Dept of Urology, Yale School of Medicine | Director, Yale Center for Health & Learning Games, Internal Medicine; Director, play2PREVENT Lab at Yale, Internal Medicine | Eda Cengiz | Elizabeth Ralevski | Ethel F. Donaghue Women's Health Investigator Program at Yale | Foundations Fund Professor of Psychiatry and Professor in the Child Study Center and of Neuroscience; Director, Yale Interdisciplinary Stress Center; Chief, Psychology Section in Psychiatry; Co-director of Education, Yale Center for Clinical Investigation | Founding Director, Olin Neuropsychiatry Center; Yale University | Founding Director Olin Research Center; Professor Yale University | Founding Director Olin Research Center; Yale University | Greenwich Hospital | Griffin Hospital | Howard Hochster | Internal medicine Department (Hematology), Yale Comprehensive Cancer Center, Yale University | Jennifer Sherr | Joseph Paul Eder | Lajos Pusztai | MED School of Medicine | Multiple Sclerosis Treatment Center, Derby, Connecticut | National Center for PTSD / Yale University | Norwalk Hospital | Prof. Dr. Gerald Shulman, Yale University, New Haven, Conneticut, USA | Professor of Dermatology Yale University | Professor of Psychiatry | Professor, Section of Infectious Diseases: Department of Internal Medicine | Profossor of Medicine, Yale School of Medicine | Psychiatry; Director Yale Stress Center | Sanjay Kulkarni | Sarah Goldberg | Stephen M. Strittmatter | The John B. Pierce Laboratory | The John B Pierce Laboratory, Yale University | The John B. Pierce Laboratory/Yale University | VACHS, Yale University School of Medicine | VAMC West Haven and Yale University | Yale- 203-737-2464 | Yale Cancer Center, Yale University | Yale Cardiovascular Research Group | Yale Center for Clinical Investigation; Yale University | Yale Center for MS Treatment and Research | Yale Department of Dermatology | Yale-Griffin Prevention Research Center | YALE-GRIFFIN PREVENTION RESEARCH CENTER | Yale Medical Group | Yale Medical School | Yale New Haven Health | Yale New Haven Health System Center for Healthcare Solutions | Yale New Haven Hospital | Yale New Haven Hospital - Yale Cancer Center | Yale-NUS College | Yale Psychiatric Institute | Yale School of Medicine | Yale School of Medicine, Assistant Professor | Yale School of Medicine, Department of Emergency Medicine | Yale School of Medicine Department of Endocrinology | Yale School of Medicine Department of Pediatric Endocrinology | Yale School of Medicine Department of Rheumatology | Yale School of Medicine (Nephrology) | Yale Stress Center - Addiction Program | Yale Univ | Yale Univerisity, School of Medicine | Yale University | Yale University AIDS Program | Yale University and VA Connecitcut Healthcare System | Yale University and VA Connecticut Healthcare System | Yale University Associate Professor | Yale University Cancer Center | Yale University Cancer Center LAO | Yale University Child Study Center | Yale University Comprehensive Cancer Center | Yale University Department of Anesthesiology | Yale University, Department of Internal Medicine, Section of Digestive Diseases, Yale School of Medicine | Yale University, Department of Psychiatry | Yale University- Department of Surgery | Yale University Digestive Diseases | Yale University - MEDCCC Hematology-Section | Yale University Medical School | Yale University, New Haven, CT 06520 | Yale University Professor of Psychiatry | Yale University School of Med. | Yale University School of Medicine/AIDS Program | Yale University School of Medicine, Assistant Professor | Yale University School of Medicine, Asst Professor | Yale University School of Medicine: Department of Dermatology | Yale University School of Medicine, Department of Emergency Medicine | Yale University School of Medicine Department of Obstetrics, Gynecology & Reproductive Sciences, Division of Gynecologic Oncology | Yale University School of Medicine Department of Obstetrics, Gynecology & Reproductive Sciences, Division of Gynecologic Specialties | Yale University School of Medicine Department of Psychiatry | Yale University, School of Medicine, Department of Psychiatry | Yale University School of Medicine, Dept of Psychiatry | Yale University School of Medicine, New Haven, CT | Yale University School of Medicine, Psychiatry | Yale University School of Medicine, Smilow Cancer Center at Yale New Haven Hospital, Yale Comprehensive Cancer Center | Yale University School of Medicine/Yale New Haven Hospital | Yale University School of Nursing | Yale University School of Public Health | Yale University, Section of Digestive Diseases | Yale University (Stage 2) | Yale University, USA | Yale University / VACHS West Haven | Yale University, VA Connecticut Healthcare System | Yale University/VA Connecticut Healthcare System | Yale University, VA CT Health System | Yale University/Veterans Affairs CT | Yale University, West Haven VA hospital | Yale University/Yale-Griffin Prevention Research Center | Yale University, Yale School of Medicine | Yale Unversity School of Medicine | Yale Unviversity School of Medicine | YUMC | Zain Husain
Highest phase reached
Phase 4
First clinical trial
Apr 1, 1983Last known activity
Aug 31, 2026
Timeline
1700s
- Oct 9, 1701
Yale University— Founded
Drugs by trial phase (634 distinct, 1004 trials)
Phase 4 (75 own, 0 via acquisition)
Phase 3 (91 own, 0 via acquisition)
Phase 2 (291 own, 0 via acquisition)
Phase 1 (122 own, 0 via acquisition)
Other trials (55 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Acute Coronary Syndrome
- Acute Kidney Injury
- Acute Pain
- Adenocarcinoma
- Aggression
- Agoraphobia
- Alcohol Drinking
- Alcoholic Intoxication
- Alcohol-Induced Disorders
- Alcoholism
- Alcohol-Related Disorders
- Alopecia
- Alopecia Areata
- Alzheimer Disease
- Amphetamine-Related Disorders
- Ancylostomiasis
- Anemia, Neonatal
- Anemia, Sickle Cell
- Aneurysm
- Angina Pectoris
- Anthrax
- Anxiety Disorders
- Arteriosclerosis
- Atrial Fibrillation
- Autism Spectrum Disorder
- Autistic Disorder
- Back Pain
- Bacterial Infections
- Bacteriuria
- Basal Cell Nevus Syndrome
- Behavior, Addictive
- beta-Thalassemia
- Binge-Eating Disorder
- Bipolar Disorder
- Birth Weight
- Blood Coagulation Disorders
- Body Weight
- Bone Resorption
- Borderline Personality Disorder
- Brain Diseases
- Brain Edema
- Brain Injuries
- Brain Neoplasms
- Breast Neoplasms
- Bronchopulmonary Dysplasia
- Bulimia
- Burns
- Cancer Pain
- Carcinoma
- Carcinoma, Acinar Cell
- Carcinoma, Hepatocellular
- Carcinoma, Neuroendocrine
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Small Cell
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Cardiac Complexes, Premature
- Cardiovascular Diseases
- Cerebral Hemorrhage
- Cervical Intraepithelial Neoplasia
- Chest Pain
- Child Development Disorders, Pervasive
- Cholangiocarcinoma
- Cholangitis
- Cholangitis, Sclerosing
- Chorioamnionitis
- Chronic Pain
- Cluster Headache
- Cocaine-Related Disorders
- Cognition Disorders
- Cognitive Dysfunction
- Colonic Neoplasms
- Colorectal Neoplasms
- Communicable Diseases
- Compulsive Personality Disorder
- Coronary Artery Disease
- Coronary Disease
- Coronavirus Infections
- Critical Illness
- Crohn Disease
- Cystadenocarcinoma, Serous
- Cystic Fibrosis
- Cystitis
- Cystitis, Interstitial
- Delirium
- Dental Caries
- Depression
- Depressive Disorder
- Depressive Disorder, Treatment-Resistant
- Developmental Disabilities
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Digestive System Neoplasms
- Dilatation, Pathologic
- Disease
- Disease Progression
Recent trials (50)
- NCT07174414CollaboratorPhase 3Aug 31, 2026
- NCT07306364Lead sponsorPhase 2Jun 30, 2026
- NCT07306364OfficialPhase 2Jun 30, 2026
- NCT07306364Sponsor investigatorPhase 2Jun 30, 2026
- NCT07189585Lead sponsorPhase 2Apr 1, 2026
- NCT07189585OfficialPhase 2Apr 1, 2026
- NCT07189585Sponsor investigatorPhase 2Apr 1, 2026
- NCT07281027Lead sponsorPhase 3Mar 1, 2026
- NCT07281027OfficialPhase 3Mar 1, 2026
- NCT07281027Sponsor investigatorPhase 3Mar 1, 2026
- NCT06996652OfficialPhase 2Jan 31, 2026
- NCT06996652Lead sponsorPhase 2Jan 31, 2026
- NCT06996652Sponsor investigatorPhase 2Jan 31, 2026
- NCT07273838Lead sponsorPhase 2Jan 31, 2026
- NCT07273838OfficialPhase 2Jan 31, 2026
Details
- Founded
- Killingworth, CT, US Oct 9, 1701
- Last known activity
- Aug 31, 2026